World Top 100 Biotechnology Companies List by Market Cap in January 2024

World Top 100 Biotechnology Companies List by Market Cap in January 2024, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as pf Jan-05-2024.

World Top Biotechnology Companies in 2024
World Largest Biotechnology Companies by Market Cap in 2024, World Top Biotechnology Companies by Market Cap in 2024.

  1. Momenta Pharmaceuticals

    World Rank (Jan-05-2024)
    5,297
    World Rank (Jul-30-2023)
    5,297
    World Rank (Dec-25-2022)
    5,297
    World Rank (Jan-07-2022)
    5,297
    Headquarters Country
    USA
    Company Profile

    Momenta Pharmaceuticals is a Biotechnology company. The headquarters is in USA.

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD.

    Facts About Company

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD

    Company Website
    MOMENTA PHARMACEUTICALS INC

  2. Bio-Thera Solutions Ltd.

    World Rank (Jan-05-2024)
    5,315
    Market Cap (Jan-05-2024)
    2.237 Billion USD
    World Rank (Jul-30-2023)
    6,264
    Market Cap (Jul-30-2023)
    1.742 Billion USD
    World Rank (Dec-25-2022)
    7,213
    Market Cap (Dec-25-2022)
    1.291 Billion USD
    World Rank (Jan-07-2022)
    7,109
    Market Cap (Jan-07-2022)
    1.63 Billion USD
    Headquarters Country
    China
    Company Website
    BIO-THERA SOLUTIONS, LTD.

  3. IDEAYA Biosciences Inc.

    World Rank (Jan-05-2024)
    5,323
    Market Cap (Jan-05-2024)
    2.231 Billion USD
    World Rank (Jul-30-2023)
    7,684
    Market Cap (Jul-30-2023)
    1.241 Billion USD
    World Rank (Dec-25-2022)
    9,463
    Market Cap (Dec-25-2022)
    0.819 Billion USD
    World Rank (Jan-07-2022)
    11,494
    Market Cap (Jan-07-2022)
    0.69 Billion USD
    Annual Revenue in USD
    51 Million USD
    Annual Operating Income in USD
    -63 Million USD
    Annual Net Income in USD
    -59 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    IDEAYA is a synthetic lethality focused precision medicine oncology company developments and discovery of targeted therapeutics for patient populations selected using molecular diagnostics. The headquarters is in USA.

    Facts About Company

    IDEAYA Annual Total Revenue for year ending Dec-2022 was 50 million USD and and Net loss for year ending Dec-2022 was -58 million USD.

    IDEAYA Annual Total Revenue for year ending Dec-2021 was 27 million USD and and Net loss for year ending Dec-2021 was -50 million USD.

    As on 2022, IDEAYA has 103 employees.

    Company Website
    IDEAYA BIOSCIENCES

  4. Shanghai Haohai Biological Technology

    World Rank (Jan-05-2024)
    5,387
    Market Cap (Jan-05-2024)
    2.185 Billion USD
    World Rank (Jul-30-2023)
    5,795
    Market Cap (Jul-30-2023)
    1.974 Billion USD
    World Rank (Dec-25-2022)
    5,819
    Market Cap (Dec-25-2022)
    1.796 Billion USD
    World Rank (Jan-07-2022)
    4,973
    Market Cap (Jan-07-2022)
    2.89 Billion USD
    Annual Revenue in USD
    255 Million USD
    Annual Net Income in USD
    51 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ HongKong
    Company Website
    SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY

  5. 3SBio

    World Rank (Jan-05-2024)
    5,389
    Market Cap (Jan-05-2024)
    2.183 Billion USD
    World Rank (Jul-30-2023)
    5,166
    Market Cap (Jul-30-2023)
    2.355 Billion USD
    World Rank (Dec-25-2022)
    4,569
    Market Cap (Dec-25-2022)
    2.591 Billion USD
    World Rank (Jan-07-2022)
    6,157
    Market Cap (Jan-07-2022)
    2.07 Billion USD
    Annual Revenue in USD
    929 Million USD
    Annual Net Income in USD
    240 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ HongKong
    Company Website
    3SBIO

  6. Simcere Pharmaceutical Group Limited

    World Rank (Jan-05-2024)
    5,399
    Market Cap (Jan-05-2024)
    2.177 Billion USD
    World Rank (Jul-30-2023)
    4,786
    Market Cap (Jul-30-2023)
    2.610 Billion USD
    World Rank (Dec-25-2022)
    3,731
    Market Cap (Dec-25-2022)
    3.392 Billion USD
    World Rank (Jan-07-2022)
    4,860
    Market Cap (Jan-07-2022)
    2.99 Billion USD
    Headquarters Country
    China
    Company Profile
    SIMCERE PHARMACEUTICAL GROUP LIMITED is a pharmaceutical company with core therapeutic areas oncology, central nervous system, autoimmunity and anti infection. The headquarters is in China.
    Company Website
    SIMCERE PHARMACEUTICAL GROUP LIMITED

  7. Chemocentryx

    World Rank (Jan-05-2024)
    5,410
    World Rank (Jul-30-2023)
    5,410
    World Rank (Dec-25-2022)
    5,410
    World Rank (Jan-07-2022)
    5,410
    Market Cap (Jan-07-2022)
    2.56 Billion USD
    Annual Revenue in USD
    32 Million USD
    Annual Net Income in USD
    -131 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile
    ChemoCentryx is a Biopharmaceutical company. It portfolio of therapeutics in areas such as orphan and rare diseases, chronic kidney disease, immuno oncology and inflammatory and autoimmune diseases. The headquarters is in USA.
    Company Website
    CHEMOCENTRYX

  8. Prothena Corporation

    World Rank (Jan-05-2024)
    5,415
    Market Cap (Jan-05-2024)
    2.168 Billion USD
    World Rank (Jul-30-2023)
    3,904
    Market Cap (Jul-30-2023)
    3.509 Billion USD
    World Rank (Dec-25-2022)
    4,044
    Market Cap (Dec-25-2022)
    3.039 Billion USD
    World Rank (Jan-07-2022)
    6,228
    Market Cap (Jan-07-2022)
    2.03 Billion USD
    Annual Revenue in USD
    200 Million USD
    Annual Net Income in USD
    66 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Ireland
    Yahoo @ Frankfurt
    Company Profile
    Prothena Corporation is a Biotechnology company with advancing a number of novel therapeutics for rare peripheral amyloid and neurodegenerative diseases. The company total assets are 332.9 million USD as on 2020. The headquarters is in Ireland.
    Company Website
    PROTHENA CORPORATION

  9. Portola Pharmaceuticals

    World Rank (Jan-05-2024)
    5,432
    World Rank (Jul-30-2023)
    5,432
    World Rank (Dec-25-2022)
    5,432
    World Rank (Jan-07-2022)
    5,432
    Headquarters Country
    USA
    Company Profile

    Portola Pharmaceuticals is a Biotechnology company. It is having more than 380 employees and has offices around the globe and serves patients in more than 50 countries. The company has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder.

  10. Celldex Therapeutics

    World Rank (Jan-05-2024)
    5,438
    Market Cap (Jan-05-2024)
    2.151 Billion USD
    World Rank (Jul-30-2023)
    6,490
    Market Cap (Jul-30-2023)
    1.640 Billion USD
    World Rank (Dec-25-2022)
    5,323
    Market Cap (Dec-25-2022)
    2.078 Billion USD
    World Rank (Jan-07-2022)
    6,911
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -107 Million USD
    Annual Net Income in USD
    -112 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Its pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Headquarters is in USA.

    Company Website
    CELLDEX THERAPEUTICS

Share